🇺🇸 IPV Vaccine in United States
26 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 26
Most-reported reactions
- Angioedema — 5 reports (19.23%)
- Paraesthesia Oral — 4 reports (15.38%)
- Off Label Use — 3 reports (11.54%)
- Abdominal Pain — 2 reports (7.69%)
- Decreased Appetite — 2 reports (7.69%)
- Depression — 2 reports (7.69%)
- Diarrhoea — 2 reports (7.69%)
- Dizziness — 2 reports (7.69%)
- Dyspnoea — 2 reports (7.69%)
- Fallot^S Tetralogy — 2 reports (7.69%)
Frequently asked questions
Is IPV Vaccine approved in United States?
IPV Vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for IPV Vaccine in United States?
PT Bio Farma is the originator. The local marketing authorisation holder may differ — check the official source linked above.